Jin et al. found that the expression of PI3K/AKT signalling pathway genes was upregulated in drug-resistant small cell lung cancer, and the use of PI3K inhibitors enhanced the sensitivity of chemotherapeutic drugs [36]. This evidence concerns the gene PIK3CB and small cell lung carcinoma.